Alexander Lifke

567 total citations
5 papers, 424 citations indexed

About

Alexander Lifke is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Alexander Lifke has authored 5 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 3 papers in Immunology and 2 papers in Molecular Biology. Recurrent topics in Alexander Lifke's work include Immunotherapy and Immune Responses (3 papers), T-cell and B-cell Immunology (2 papers) and CAR-T cell therapy research (2 papers). Alexander Lifke is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), T-cell and B-cell Immunology (2 papers) and CAR-T cell therapy research (2 papers). Alexander Lifke collaborates with scholars based in Germany and Switzerland. Alexander Lifke's co-authors include Volker Lennerz, Catherine Wölfel, Christoph Huber, Thomas Wölfel, Martina Fatho, Chiara Gentilini, Roy A. Frye, Natascha Rieder, Frieder Bauss and Gwendlyn Kollmorgen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Cancer Research.

In The Last Decade

Alexander Lifke

5 papers receiving 418 citations

Peers

Alexander Lifke

IMMUN

ONCOL

MB

RNMI

CR

Francesca Avogadri-Connors United States

F.M. Marincola United States

Jeannine Alexander United States

Jill Stanley United States

Peishan Lee Singapore

Andy N. Tran United States

Erica Hansen United States

A. Benhammouda France

Peterson Kariuki Maina United States

Dora Hammerl Netherlands

Francesca Avogadri-Connors United States

Alexander Lifke

128 ×0.4

IMMUN

175 ×0.6

ONCOL

120 ×0.8

MB

21 ×0.5

RNMI

22 ×0.6

CR

Citations per year, relative to Alexander Lifke Alexander Lifke (= 1×) peers Francesca Avogadri-Connors

Countries citing papers authored by Alexander Lifke

Since Specialization

Citations

This map shows the geographic impact of Alexander Lifke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Lifke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Lifke more than expected).

Fields of papers citing papers by Alexander Lifke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Lifke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Lifke. The network helps show where Alexander Lifke may publish in the future.

Co-authorship network of co-authors of Alexander Lifke

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Lifke. A scholar is included among the top collaborators of Alexander Lifke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Lifke. Alexander Lifke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Hillringhaus, Lars, Olaf Mundigl, Glòria Tabarés, et al.. (2019). Sensitization of Tumors for Attack by Virus-Specific CD8+ T-Cells Through Antibody-Mediated Delivery of Immunogenic T-Cell Epitopes. Frontiers in Immunology. 10. 1962–1962. 19 indexed citations

2.

Kollmorgen, Gwendlyn, Alexander Lifke, Adam Nopora, et al.. (2014). Abstract 2667: RG7287, a novel humanized anti-CDCP1 antibody with superior preclinical in vivo efficacy in combination with Paclitaxel. Cancer Research. 74(19_Supplement). 2667–2667. 1 indexed citations

3.

Kollmorgen, Gwendlyn, Gerhard Niederfellner, Alexander Lifke, et al.. (2013). Antibody mediated CDCP1 degradation as mode of action for cancer targeted therapy. Molecular Oncology. 7(6). 1142–1151. 26 indexed citations

4.

Lennerz, Volker, Martina Fatho, Chiara Gentilini, et al.. (2005). The response of autologous T cells to a human melanoma is dominated by mutated neoantigens. Proceedings of the National Academy of Sciences. 102(44). 16013–16018. 348 indexed citations

5.

Schmidt, Andrea, Matthias Glückmann, Christian Albrecht, et al.. (2004). CD8+ cytotoxic T lymphocytes isolated from allogeneic healthy donors recognize HLA class Ia/Ib–associated renal carcinoma antigens with ubiquitous or restricted tissue expression. Blood. 104(8). 2591–2599. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact